TMDX TransMedics Group, Inc.
Company Analysis
Latest News
TransMedics Appoints New CFO Fernando Araujo, Reaffirms 2026 Revenue Guidance
TransMedics announced the appointment of Fernando Araujo as its new Chief Financial Officer and Treasurer, effective September 21, 2026. Mr. Araujo, previously...
🔴 TransMedics Group is trading 5% down in after-hours trading as Nasdaq Composite falls 0.65%
TransMedics Group is trading at $85.76, down 4.69% in after-hours trading amid weaker broader-market sentiment after closing at $89.98 on September 4, 2026. -...
🔴 TransMedics Group is trading 4.38% down today after no clear company-specific announcement was identified
TransMedics Group is trading at $84.56 (-4.38%) after no clear company-specific announcement was identified for August 31, 2026. • Recent filings list August...
🟢 TransMedics Group is trading 4.09% up today as healthcare stocks rally
TransMedics Group is trading 4.09% up at $94.57 as healthcare stocks rally alongside broader risk-on sentiment. - No clear company-specific announcement...
🟢 TransMedics Group rises 4.4% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation
With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...
🟢 TransMedics Group rises 4.2% — Healthcare Sector Rallies on Defensive Rotation Amid Broad Market Weakness
With Healthcare (XLV) up 1.6%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector, as measured by the XLV ETF,...
🟢 TransMedics Group is trading 4% up today after record revenue and raised 2026 guidance
TransMedics Group is trading at $87.28, up +4.04%, driven by record quarterly revenue and higher 2026 guidance. • Shares are extending their rebound after...
TransMedics Posts Record Revenue and Lifts Guidance — But Can the Margin Squeeze Fund Its Ambitions Without Punishing Shareholders?
Shares surged 10% to $88.80 in after-hours trading after TransMedics, the company behind portable organ-preservation systems used in transplant surgery, posted...
🟢 TransMedics Group is trading 4.1% up today as investors process August 4 earnings
TransMedics Group is trading 4.1% up at $79.60, rebounding from the 5.28% decline on August 5 as investors continue processing the August 4 earnings report. -...
🔴 TransMedics Group is trading 13.6% down today on EPS miss and margin concerns despite revenue beat
TransMedics Group is trading 13.6% down at $72.44 after its Q2 2026 earnings report showed an EPS miss driven by a 49% surge in operating expenses. • The...
🔴 TransMedics Group is trading 10.1% down today after Q2 EPS miss and rising costs
TransMedics Group is trading 10.1% down at $72.57 in pre-market action after its second-quarter report showed an earnings miss driven by a significant surge in...
🔴 TransMedics Group is trading 7.9% down today on Q2 earnings miss and rising costs
TransMedics Group is trading 7.9% down at $74.38 after its second-quarter report showed strong revenue growth but weaker-than-expected profitability. •...
🔴 TransMedics Group is trading 4.6% down today after missing Q2 earnings estimates on rising costs
TransMedics Group is trading at $77.01 (-4.63%) in after-hours trading after a mixed second-quarter earnings report saw an earnings miss and rising costs...
🟢 TransMedics Group is trading 10% up today after Q2 revenue beat and raised guidance
TransMedics Group is trading 10% up at $88.80 in after-hours trading after reporting second-quarter 2026 results that surpassed top-line estimates. • Revenue...
TransMedics' second quarter revenue of $190M beat estimates, but EPS missed amid rising operating costs.
TransMedics reported second quarter 2026 revenue of $189.9 million, up 21% year-over-year, beating analyst expectations of $184.2 million. However, diluted...
🟢 TransMedics Group is trading 4% up today ahead of Q2 earnings report
TransMedics Group is trading 4% up at $79.75 as traders position themselves ahead of the company's Q2 2026 earnings report scheduled for August 04, 2026. •...
TransMedics Group Inc Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
For Q2 2026, TransMedics is expected to report consensus revenue of $184.17 million and earnings per share of $0.50, with the stock currently trading at $74.29...
🔴 TransMedics Group is trading 4.2% down today with no fresh news or catalysts
TransMedics Group is trading 4.2% down at $74.75 as the move appears to be driven by normal volatility and positioning after prior gains, with no fresh...
🟢 TransMedics Group is trading 4.4% up today, rebounding from a sharp selloff triggered by cautious analyst commentary
TransMedics Group is trading at $74.35 (4.4%) up, rebounding from sharp losses in the previous session tied to cautious analyst commentary and execution...
TransMedics Completes Strategic Investment in German Aviation Firm to Expand in Europe
TransMedics Group, Inc. finalized a strategic investment in PAD Aviation service GmbH. PAD Aviation service GmbH operates as a private aviation operator based...